Lv2
170 积分 2024-02-29 加入
Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes
2天前
已完结
Reply: Survival analysis pitfalls in MASLD—Proportional hazards, immortal time, and follow-up discrepancies
14天前
已关闭
Association between longitudinal weight change and clinical outcome in individuals with MASLD
19天前
已完结
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
19天前
已完结
Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes
1个月前
已完结
Associations of Accelerometer-Derived Moderate-to-Vigorous Physical Activity and Atrioventricular Block in a Healthy Elderly Population
1个月前
已关闭
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
1个月前
已完结
Comparison of diagnostic criteria for fatty liver disease in assessing cardiac dysfunction: a cross-sectional study
1个月前
已完结
Electrocardiographic abnormalities in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
1个月前
已完结
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
皖公网安备34019202002308
